n normal rabbits on a high-cholesterol diet we observed that reducing dietary potassium intake from normal (1.5%, plasma potassium concentration ϭ 4.3 mmol/L) to a low level (0.4%, plasma potassium concentration ϭ 3.9 mmol/L) increased the number of arteriosclerotic arteries in the myocardium by approximately 50%.
I
n normal rabbits on a high-cholesterol diet we observed that reducing dietary potassium intake from normal (1.5%, plasma potassium concentration ϭ 4.3 mmol/L) to a low level (0.4%, plasma potassium concentration ϭ 3.9 mmol/L) increased the number of arteriosclerotic arteries in the myocardium by approximately 50%. 1 More recently, we reported that elevation of dietary potassium intake reduced the severity of neointimal proliferative lesion formation in the arteries of rats and pigs after balloon angioplasty. In the study in normal adult rats, increasing potassium in the diet from a low level (0.1%) to a high level (4.0%) reduced the neointimal to medial area ratio by 46%, in association with an increase in plasma potassium concentration from 4.3 to 5.8 mmol/L. 2 In the coronary artery of pigs after balloon angioplasty, the neointimal to medial area ratio was reduced by 45% in association with an increase in dietary potassium intake from 0.25% (plasma potassium concentration ϭ 3.1 mmol/L) to 2.0% (plasma potassium concentration ϭ 4.0 mmol/L).
The etiology of formation of both the arteriosclerotic lesion and the neointimal proliferative lesion associated with angioplasty have been studied extensively. 4 -7 Growth factors released at the site by platelets, endothelial cells, white blood cells, and vascular smooth muscle cells stimulate migration of vascular smooth muscle cells from the media to the subintima, where they subsequently proliferate and synthesize extracellular matrix proteins. Migration to the point of injury is directed by platelet-derived growth factor BB (PDGF-BB), 8 -11 , whereas basic fibroblast growth factor (bFGF) and PDGF-BB are the prominent regulators of vascular smooth muscle cell proliferation. 6, 8, 9, 12, 13 Transforming growth factor beta 1 (TGF-␤1) stimulates synthesis of collagen and other extracellular matrix proteins by vascular smooth muscle cells in the subintima. 5, 14 The mechanism of the observed inhibition of arteriosclerotic lesion formation and neointimal proliferation by elevation of potassium intake may have included effects of extracellular potassium concentration on the release of these cytokines, or on their actions on vascular smooth muscle cell proliferation and migration.
In this study we analyzed the effects of changes in extracellular potassium concentration in a physiologic range on the actions of PDGF-BB, bFGF, and 5% fetal bovine serum (5% FBS) to stimulate proliferation of vascular smooth muscle cells in vitro. The responses of vascular smooth muscle cells derived from explants of pig coronary arteries to the cytokines most important in the etiology of vascular lesions were assessed in media with potassium concentrations ranging from 3 to 6 mmol/L. Both DNA synthesis and cell proliferation were analyzed during changes in potassium concentration lasting from 1 to 7 days.
MATERIALS AND METHODS

Vascular Smooth Muscle Cell Isolation and Culture
Vascular smooth muscle cells were obtained from microdissected explants of the left circumflex coronary artery of castrated male, 6-to 8-week-old common swine. Connective-tissue-free pieces of medial vascular smooth muscle were placed in culture dishes with 10% fetal bovine serum (FBS) in Dulbecco's modified Eagle medium (DMEM) with penicillin 100 U/mL, streptomycin 100 g/mL, and gentamicin 25 g/mL. The cells were passaged once and stored frozen at Ϫ80°C or in liquid nitrogen. After thawing, they were grown in 5% FBS in DMEM with penicillin 100 U/mL, streptomycin 100 g/mL, and gentamicin 25 g/mL before being studied. The selectivity of the isolation technique and the purity of the cultures were analyzed in four isolations by immunohistochemical staining in passage 3 for alpha smooth muscle actin and for vimentin for fibroblasts. 15 All of the cells were positive for actin, and no cells were positive for vimentin.
The vascular smooth muscle cells were maintained in 5% CO 2 / room air, Ͼ 95% relative humidity at 37°C, subcultured 1:3 on reaching 80% confluence, and used at passage 3 to 5.
Vascular Smooth Muscle Cell Proliferation
Vascular smooth muscle cells (passage 3) were plated 25,000 cells/well in 12-well plates and grown for 48 h in DMEM without growth factors, and in extracellular potassium concentration of 4 mmol/L, sodium concentration of 140 mmol/L, to induce quiescence.
On day 0, cells were exposed to DMEM with 20 ng/ml PDGF-BB, 25 ng/ml bFGF with 0.5% FBS in DMEM, or 5% FBS, with final extracellular potassium concentrations ranging in 1.0-mmol/L increments from 3.0 to 6.0 mmol/L. Cells were harvested on day 7. At the end of incubation, the plates were washed with ice-cold phosphate buffered saline (PBS, without calcium and magnesium) twice and once with EDTA, then incubated in a known volume of PBS solution containing 2.5 g/L of trypsin for 14 min at 37°C in the incubator. Cells were mixed 2:1 in a solution of (w/v) 0.4% trypan blue, 0.81% NaCl, and 0.06% K 2 HPO 4 . Cells were counted three times with a hemocytometer at 100ϫ for each extracellular potassium concentration for each well (triplicate cultures). Six 12-well plates were analyzed for each agonist.
DNA Synthesis
Stimulation of DNA synthesis was measured by analyzing the incorporation of [methyl 3 H] thymidine. Vascular smooth muscle cells were seeded at a density of 35,000 cells/mL (for PDGF-BB, bFGF studies) or 25,000 cells/mL (for 5% FBS study) in 12-well plates and allowed to attach and become quiescent for 48 h in serum-free DMEM to arrest growth of the cells in the G 0 phase of the cell cycle. The extracellular potassium concentration of the medium was 4 mmol/L, sodium concentration was 140 mmol/L. DNA synthesis was stimulated by 20 ng/mL PDGF-BB, 25 ng/mL bFGF, and 5% FBS. Growth stimulation was studied with medium containing growth factors or serum with different concentration of potassium (3, 4, 5, or 6 mmol/L) and [methyl 3 H] thymidine (2.0 uCi/mL) for a 24-h incubation period (determined from time-course experiments). At the end of incubation, the plates were placed on ice, washed with icecold phosphate-buffered saline (PBS, without calcium and magnesium) twice, and incubated with ice-cold trichloroacetic acid (TCA, 10%, wt/vol) for 20 min. TCA precipitates thus formed were solubilized by adding 1% sodium dodecyl sulfate (SDS), 0.1 N NaOH overnight at room temperature. Precipitated DNA was harvested onto Whatman GF/B glass fiber filter mats. The filters were washed twice with 10% TCA and once with absolute ethanol. The radioactivity was counted by liquid scintillation counting. Six 12-well plates were analyzed for each agonist.
Data Analysis Data are expressed as percentages of the mean values for data from the wells containing 4 mmol/L potassium within each experiment. Group means and standard errors of the mean are presented in the figures. One-way analysis of variance was used to test for significance of effects of potassium concentration for each agonist. When analysis of variance suggested a significant difference among groups, group means were tested for difference using Dunnett's modification of Student's t test for independent measures. Correlation coefficients were calculated and are presented in the text with their associated probability values. A probability value of less than 5% was considered to be significant.
RESULTS
Effect of Potassium Concentration on Vascular
Smooth Muscle Cell Proliferation A significant inverse relation was found between extracellular potassium concentration and vascular smooth muscle cell proliferation stimulated by either PDGF-BB, bFGF, or 5% FBS (all P Ͻ .01 ANOVA, r ϭ Ϫ0.62, Ϫ0.26, and Ϫ0.56 for PDGF-BB, bFGF, and 5% FBS, respectively, all P Ͻ .01). The effect of potassium concentration on vascular smooth muscle cell proliferation stimulated by PDGF-BB (20 ng/mL) and bFGF (25 ng/mL) are presented in Figs. 1A and B. Proliferation stimulated by 20 ng/ml PDGF-BB ranged from 143 Ϯ 21% in potassium concentration of 3 mmol/L to 58 Ϯ 7% in potassium concentration of 6 mmol/L (100% ϭ value in potassium concentration of 4 mmol/L). The limits of proliferation stimulated by bFGF were 114 Ϯ 39% in potassium concentration of 3 mmol/L and 84 Ϯ 29% in potassium concentration of 6 mmol/L, whereas the range of proliferation stimulated by 5% FBS ( Figure  1C ) was from 106 Ϯ 10% in potassium concentration of 3 mmol/L to 77 Ϯ 4% in potassium concentration of 6 mmol/L.
Smooth Muscle Cell DNA Synthesis A significant inverse relation also was found between potassium concentration and thymidine incorporation in vascular smooth muscle cells stimulated by 20 ng/mL PDGF-BB, shown in Fig. 2A (P Ͻ .01 ANOVA, r ϭ Ϫ0.49, P Ͻ .01). Raising potassium concentration to 6 mmol/L reduced 3 H-thymidine to 61 Ϯ 4% of the value observed in the control potassium concentration (4 mmol/L). Similarly, DNA synthesis stimulated by bFGF (25 ng/mL in DMEM) was inhibited by increases in potassium concentration (P Ͻ .01 ANOVA, r ϭ Ϫ0.47, P Ͻ .01) shown in Figure 2B . 3 H-thymidine incorporation ranged from 106 Ϯ 6% in potassium concentration of 3 mmol/L to 76 Ϯ 5% in potassium concentration of 6 mmol/L. A significant inverse relation was found between potassium concentration and thymidine incorporation in cells stimulated by 5% FBS as well (P Ͻ .01 ANOVA, r ϭ Ϫ0.62, P Ͻ .01), shown in Fig. 2C . 3 H-thymidine incorporation ranged from 111 Ϯ 4% in potassium concentration of 3 mmol/L to 81 Ϯ 3% in potassium concentration of 6 mmol/L (P Ͻ .01 v potassium concentration of 4 mmol/L). Thus, physiologic elevation of potassium concentration opposes the effect of PDGF-BB, bFGF, and serum cytokines to stimulate DNA synthesis.
DISCUSSION
The concentrations of potassium used in the study were chosen to span the physiologic range in normal humans and experimental animals, from 3 to 6 mmol/L. The upper end of the range exceeds the concentrations seen in most people eating normal healthy Western diets, but may be approached by members of primitive populations eating unrefined foods. 16 -18 Platelet-derived growth factor-BB 7, 9, 19 and bFGF 6, 20, 21 were chosen for study because of their documented importance in formation of vascular lesions associated with arteriosclerosis and balloon injury. At potassium concentrations from 3 to 6 mmol/L, cell counts in medium containing PDGF-BB ranged in a nearly linear manner from 135% of the control value in 3 mmol/L potassium to 63% in a potassium concentration of 6 mmol/L. Cell proliferation stimulated by bFGF was also sensitive to increases in potassium concentration, although the magnitude of the inhibition was approximately half as great as in the studies done with PDGF-BB. Thymidine incorporation showed highly significant inverse relationships to medium potassium concentrations with both PDGF-BB and bFGF as agonists. The thymidine incorporation data were quantitatively similar to the cell count data in the case of bFGF; however, for PDGF-BB thymidine incorporation studies, although the ANOVA analysis of the data set suggested a highly significant inverse relationship between potassium concentration and thymidine incorporation, the value at the 3 mmol/L concentration was 20% less than the value at the normal concentration, 4 mmol/L. In none of the other experiments conducted in this series of studies using cultured vascular smooth muscle cells was a similar finding observed. No explanation for this isolated result is available at this time. Serum was also used as an agonist because it contains other cytokines in addition to PDGF and bFGF that may contribute to the proliferative response of vascular smooth muscle cells. The inhibitory effect of increases in potassium concentration against 5% FBS were quantitatively similar to those observed with PDGF and bFGF. Therefore, the inhibitory action may be effective against generalized mechanisms regulating proliferation.
The effects of increases in potassium concentration on cell proliferation and DNA synthesis may be mediated by stimulation of the activity or expression of sodium, potassium-ATPase in the cell membrane, which would decrease intracellular sodium concentration and increase the concentration gradient driving the sodium-calcium exchange mechanism. This is the hypothesis proposed by Canadry et al to account for the inhibition by potassium of cell proliferation and DNA synthesis in glial cells in culture. 22 In studies in vascular smooth muscle cells, the reduction in tension associated with elevation of potassium concentration in the physiologic range has been attributed by Haddy and co-workers to an increase in sodium, potassiumATPase activity. [23] [24] [25] Also, Songu-Mize et al demonstrated that physiologic increases in dietary potassium intake or in plasma potassium concentration act in vivo to increase vascular smooth muscle sodium, potassium-ATPase activity. 26 Intracellular sodium concentration is known to increase markedly prior to initiation of vascular smooth muscle proliferation; 27 increases in extracellular potassium concentration from 3 to 7 mmol/L were shown by McCabe 28 to reduce by 74% the increase in intracellular sodium concentration in vascular smooth muscle just before serum-stimulated proliferation. Jones recorded an increase in sodium efflux in response to elevation of extracellular potassium concentration from vascular smooth muscle cells in vitro. 29 Similarly, in other cell types increased expression of sodium, potassium- ATPase in the cell membrane has been associated with a reduction in intracellular sodium concentration. 30 Any reduction in intracellular sodium concentration associated with elevation of extracellular potassium concentration could be expected to stimulate calcium extrusion from the cell by the sodium-calcium exchange mechanism, and subsequently, lead to a reduction in intracellular calcium concentration. The multiple signaling pathways activated by growth factors (both G-protein-linked and tyrosine-kinase-linked) invariably include increases in intracellular calcium. [31] [32] [33] [34] [35] Any increase in calcium extrusion, resulting from increased activity of the sodium, potassiumATPase, or sodium-calcium exchange, would downregulate the calcium-dependent signaling pathways leading to proliferation.
Calcium also plays a role in regulating the transcription of immediate early genes at the G 0 /G 1 transition. 36 -38 The role of calcium in late G 1 is speculative, but there are indications that it may contribute to the onset of DNA synthesis by removing inhibitory effects of suppressors such as the retinoblastoma gene. In addition to these effects during G 1 calcium has signaling effects during G 2 /M to help complete the cycle by promoting the events that culminate in cell division. Each of these steps could be inhibited by a reduction in calcium concentration associated with elevation of extracellular potassium concentration.
This series of experiments was undertaken to investigate the possible mechanisms responsible for the vascular protective effects of high levels of dietary potassium intake. Elevation of extracellular potassium concentration within the physiologic range was found to inhibit in vitro vascular smooth muscle cell thymidine incorporation and proliferation stimulated by PDGF-BB, bFGF, and 5% FBS. Suppression of these functions could be responsible in part for the reduction in formation of arteriosclerotic and neointimal proliferative lesions observed in animals given high potassium diets. [1] [2] [3] 
